‘Lupin has gained significant momentum towards development of biosimilar products with primary…
Lupin Biotech, with a new-age R&D facility in Pune, is developing and commercialising biosimilars globally. The successful…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Home » biosimilar
Browsing Tag
biosimilar
FDA puts in efforts to help make development of biosimilar and interchangeable insulin products
Consistent, life-long access to insulin is imperative to patient survival and quality of life, says American pediatrician Adm…
Novartis’s Sandoz licenses proposed multiple sclerosis biosimilar
The medicine is in Phase III clinical development for the treatment of relapsing-remitting multiple sclerosis (RRMS)
Dr Reddy’s launches Roche’s Avastin biosimilar in India
The company now has six biosimilar products commercialised in India and various emerging markets
Mylan and Biocon launch first Trastuzumab Biosimilar, Ogivri, in Australia
Ogivri is the first trastuzumab biosimilar approved and launched in Australia and available on the Pharmaceutical Benefits Scheme…
Dr Reddy’s and TR-Pharm in agreement
TR-Pharm will manufacture the drug substance and drug product upon completion of its facility investment in Turkey
Generic opportunities outweigh challenges emanating across emerging markets: ICRA
Supported by acquisitions, geographic expansion and steadily expanding product portfolio, the top-10 pharma companies from India…
Intas launches RAZUMAB, the first biosimilar to Lucentis (ranibizumab)
Ranibizumab is indicated for the treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD), a common degenerative…
Syngene seeks approval for IPO, files DRHP
Offer allows Biocon to monetise its shareholding in Syngene